News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
768,522 Results
Type
Article (49423)
Company Profile (335)
Press Release (718736)
Multimedia
Podcasts (159)
Webinars (25)
Section
Business (214780)
Career Advice (2311)
Deals (37514)
Drug Delivery (152)
Drug Development (85785)
Employer Resources (179)
FDA (17224)
Job Trends (15933)
News (365164)
Policy (35179)
Tag
2027 BioCapital Elite (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (4)
Academia (2750)
Accelerated approval (44)
Adcomms (34)
Allergies (174)
Alliances (52638)
ALS (208)
Alzheimer's disease (1809)
Antibody-drug conjugate (ADC) (440)
Approvals (17533)
Artificial intelligence (659)
Autoimmune disease (251)
Automation (52)
Bankruptcy (382)
Best Places to Work (12020)
BIOSECURE Act (22)
Biosimilars (222)
Biotechnology (195)
Bladder cancer (185)
Brain cancer (72)
Breast cancer (720)
Cancer (5698)
Cardiovascular disease (493)
Career advice (1954)
Career pathing (46)
CAR-T (325)
CDC (67)
Celiac Disease (2)
Cell therapy (866)
Cervical cancer (44)
Clinical research (73775)
Collaboration (2089)
Company closure (5)
Compensation (1341)
Complete response letters (88)
COVID-19 (2870)
CRISPR (110)
C-suite (1072)
Cystic fibrosis (157)
Data (7407)
Decentralized trials (3)
Denatured (44)
Depression (166)
Dermatology (71)
Diabetes (583)
Diagnostics (7063)
Digital health (53)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (322)
Drug pricing (231)
Drug shortages (38)
Duchenne muscular dystrophy (275)
Earnings (93699)
Editorial (72)
Employer branding (22)
Employer resources (159)
Events (125167)
Executive appointments (1093)
FDA (20814)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1700)
Gene editing (232)
Generative AI (62)
Gene therapy (708)
GLP-1 (1165)
Government (5052)
Grass and pollen (7)
Guidances (403)
Healthcare (19719)
HIV (79)
Huntington's disease (53)
IgA nephropathy (97)
Immunology and inflammation (314)
Immuno-oncology (93)
Indications (165)
Infectious disease (3217)
Inflammatory bowel disease (215)
Inflation Reduction Act (14)
Influenza (134)
Intellectual property (284)
Interviews (358)
IPO (17182)
IRA (58)
Job creations (4231)
Job search strategy (1643)
JPM (71)
Kidney cancer (19)
Labor market (95)
Layoffs (619)
Leadership (43)
Legal (8693)
Liver cancer (100)
Longevity (30)
Lung cancer (760)
Lymphoma (419)
Machine learning (56)
Management (62)
Manufacturing (1008)
MASH (190)
Medical device (14164)
Medtech (14246)
Mergers & acquisitions (21524)
Metabolic disorders (1563)
mRNA (201)
Multiple sclerosis (185)
NASH (21)
Neurodegenerative disease (413)
Neuropsychiatric disorders (111)
Neuroscience (3313)
Neurotech (1)
NextGen: Class of 2026 (6919)
Non-profit (4797)
Now hiring (74)
Obesity (764)
Opinion (333)
Ovarian cancer (201)
Pain (261)
Pancreatic cancer (270)
Parkinson's disease (362)
Partnered (34)
Patents (578)
Patient recruitment (635)
Peanut (64)
People (62678)
Pharmaceutical (95)
Pharmacy benefit managers (36)
Phase 1 (22973)
Phase 2 (32349)
Phase 3 (24236)
Pipeline (7621)
Policy (353)
Postmarket research (2810)
Preclinical (9774)
Press Release (68)
Prostate cancer (292)
Psychedelics (53)
Radiopharmaceuticals (330)
Rare diseases (1085)
Real estate (6501)
Recruiting (72)
Regulatory (26714)
Reports (55)
Research institute (2534)
Resumes & cover letters (388)
Rett syndrome (34)
RNA editing (22)
RSV (96)
Schizophrenia (178)
Series A (282)
Series B (212)
Service/supplier (14)
Sickle cell disease (117)
Special edition (28)
Spinal muscular atrophy (172)
Sponsored (47)
Startups (3876)
State (2)
Stomach cancer (20)
Supply chain (133)
Tariffs (104)
The Weekly (112)
Vaccines (1149)
Venture capital (106)
Weight loss (524)
Women's health (116)
Worklife (22)
Date
Today (150)
Last 7 days (706)
Last 30 days (2598)
Last 365 days (31265)
2026 (9572)
2025 (31266)
2024 (36372)
2023 (41197)
2022 (52413)
2021 (57030)
2020 (55675)
2019 (48612)
2018 (36758)
2017 (33932)
2016 (33750)
2015 (39602)
2014 (33555)
2013 (28772)
2012 (30897)
2011 (31603)
2010 (29914)
Location
Africa (860)
Alabama (92)
Alaska (7)
Arizona (348)
Arkansas (16)
Asia (44013)
Australia (7057)
California (12666)
Canada (3636)
China (1345)
Colorado (545)
Connecticut (548)
Delaware (384)
Europe (95514)
Florida (1925)
Georgia (406)
Hawaii (3)
Idaho (63)
Illinois (1035)
India (89)
Indiana (591)
Iowa (23)
Japan (525)
Kansas (132)
Kentucky (47)
Louisiana (40)
Maine (75)
Maryland (1543)
Massachusetts (9137)
Michigan (360)
Minnesota (696)
Mississippi (6)
Missouri (145)
Montana (34)
Nebraska (29)
Nevada (141)
New Hampshire (85)
New Jersey (3392)
New Mexico (31)
New York (3350)
North Carolina (1669)
North Dakota (9)
Northern California (6272)
Ohio (379)
Oklahoma (25)
Oregon (48)
Pennsylvania (2567)
Puerto Rico (29)
Rhode Island (51)
South America (1274)
South Carolina (83)
South Dakota (2)
Southern California (4979)
Tennessee (206)
Texas (2013)
United States (45196)
Utah (382)
Vermont (1)
Virginia (314)
Washington D.C. (82)
Washington State (1020)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
768,522 Results for "dainippon sumitomo pharma america inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition
December 9, 2025
·
14 min read
Press Releases
Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting
November 3, 2025
·
9 min read
Press Releases
Sumitomo Biorational Company Marks Official Launch with Inauguration Event
April 8, 2026
·
3 min read
Press Releases
Tanabe Pharma America Announces Finalization of RADICAVA (edaravone) Transfer to Shionogi
April 2, 2026
·
7 min read
Press Releases
Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis
July 30, 2025
·
4 min read
Press Releases
Pete Pharma and Fagron Enter Strategic Distribution Partnership to Expand Access to Pharmaceutical 3D Printing Across North America
April 17, 2026
·
2 min read
Press Releases
Tanabe Pharma America to Highlight Research in ALS at 2026 MDA Clinical and Scientific Conference
March 5, 2026
·
6 min read
Press Releases
Sumitomo Pharma America Announces that Nuvisertib (TP-3654) Has Received FDA Fast Track Designation for the Treatment of Myelofibrosis
June 13, 2025
·
5 min read
Press Releases
Mitsubishi Tanabe Pharma America is Now Tanabe Pharma America
December 2, 2025
·
2 min read
Press Releases
Sumitomo Pharma America Presents New Data on Vibegron at the 2025 American Urological Association Annual Meeting
April 30, 2025
·
7 min read
1 of 76,853
Next
